Literature DB >> 11467946

Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity.

K M Seré1, M P Janssen, G M Willems, G Tans, J Rosing, T M Hackeng.   

Abstract

Protein S, the cofactor of activated protein C (APC), also expresses anticoagulant activity independent of APC by directly inhibiting prothrombin activation via interactions with factor Xa, factor Va, and phospholipids. In different studies, however, large variations in APC-independent anticoagulant activities have been reported for protein S. The investigation presented here shows that within purified protein S preparations different forms of protein S are present, of which a hitherto unrecognized form (<5% of total protein S) binds with high affinity to phospholipid bilayers (K(d) < 1 nM). The remaining protein S (>95%) has a low affinity (K(d) = 250 nM) for phospholipids. Using their different affinities for phospholipids, separation of the forms of protein S was achieved. Native polyacrylamide gel electrophoresis demonstrated that the form of protein S that binds to phospholipids with low affinity migrated as a single band, whereas the high-affinity protein S exhibited several bands that migrated with reduced mobility. Size-exclusion chromatography revealed that the slower-migrating bands represented multimeric forms of protein S. Multimeric protein S (<5% of total protein S) appeared to have a 100-fold higher APC-independent anticoagulant activity than the abundant form of protein S. Comparison of purified protein S preparations that exhibited a 4-fold difference in APC-independent anticoagulant activity showed that the ability to inhibit prothrombin activation correlated with the content of multimeric protein S. Multimeric protein S could not be identified in normal human plasma, and it is therefore unlikely that this form of protein S contributes to the APC-independent anticoagulant activity of protein S that is observed in plasma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11467946     DOI: 10.1021/bi002500a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Analyses of protein S function.

Authors:  Kenneth G Mann
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

2.  The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.

Authors:  Matthew Ndonwi; Elodee A Tuley; George J Broze
Journal:  Blood       Date:  2010-05-17       Impact factor: 22.113

3.  Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency.

Authors:  Elisabetta Castoldi; Lisbeth F A Maurissen; Daniela Tormene; Luca Spiezia; Sabrina Gavasso; Claudia Radu; Tilman M Hackeng; Jan Rosing; Paolo Simioni
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

4.  Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.

Authors:  Pansakorn Tanratana; Paul Ellery; Pamela Westmark; Alan E Mast; John P Sheehan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-02       Impact factor: 8.311

5.  Zn²(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.

Authors:  N Fernandes; L O Mosnier; L Tonnu; M J Heeb
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

6.  The thrombin-sensitive region of protein S mediates phospholipid-dependent interaction with factor Xa.

Authors:  Subramanian Yegneswaran; Tilman M Hackeng; Philip E Dawson; John H Griffin
Journal:  J Biol Chem       Date:  2008-09-10       Impact factor: 5.157

7.  Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.

Authors:  Tilman M Hackeng; Kristin M Seré; Guido Tans; Jan Rosing
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

8.  Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.

Authors:  Mary J Heeb; Duane Prashun; John H Griffin; Bonno N Bouma
Journal:  FASEB J       Date:  2009-02-24       Impact factor: 5.191

9.  Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain.

Authors:  Helena M Andersson; Márcia J Arantes; James T B Crawley; Brenda M Luken; Sinh Tran; Björn Dahlbäck; David A Lane; Suely M Rezende
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

10.  Human Cytomegalovirus Nuclear Capsids Associate with the Core Nuclear Egress Complex and the Viral Protein Kinase pUL97.

Authors:  Jens Milbradt; Eric Sonntag; Sabrina Wagner; Hanife Strojan; Christina Wangen; Tihana Lenac Rovis; Berislav Lisnic; Stipan Jonjic; Heinrich Sticht; William J Britt; Ursula Schlötzer-Schrehardt; Manfred Marschall
Journal:  Viruses       Date:  2018-01-13       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.